2504 Genomic predictive and prognostic factors from plasma cell-free DNA (cfDNA) for metastatic castration-resistant prostate cancer (mCRPC) patients (pts) commencing enzalutamide (ENZ). (September 2015) - Chi, K.; Azad, A.; Volik, S.; Haegert, A.; Zalcberg, J.; Le Bihan, S.; McConeghy, B.; Gleave, M.; Wyatt, A.; Collins, C.